Investor doubts about Wegovy copycats weigh on health startups
US health start-ups profiting from shortages of wildly popular anti-obesity drugs such as Wegovy are facing questions over the sustainability...
US health start-ups profiting from shortages of wildly popular anti-obesity drugs such as Wegovy are facing questions over the sustainability...